Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.

Pasipanodya JG, Gumbo T.

Clin Infect Dis. 2013 Jul;57(1):21-31. doi: 10.1093/cid/cit167. Erratum in: Clin Infect Dis. 2013 Oct;57(8):1223.

2.
3.

A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis.

Burman WJ, Dalton CB, Cohn DL, Butler JR, Reves RR.

Chest. 1997 Jul;112(1):63-70.

PMID:
9228359
4.

Directly observed treatment for tuberculosis in pharmacies compared with self-administered therapy in Spain.

Juan G, Lloret T, Perez C, Lopez P, Navarro R, Ramón M, Cortijo J, Morcillo EJ.

Int J Tuberc Lung Dis. 2006 Feb;10(2):215-21.

PMID:
16499264
5.

Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.

Moonan PK, Weis SE.

Clin Infect Dis. 2013 Oct;57(7):1062-3. doi: 10.1093/cid/cit431. No abstract available.

6.

Directly observed therapy for treating tuberculosis.

Karumbi J, Garner P.

Cochrane Database Syst Rev. 2015 May 29;(5):CD003343. doi: 10.1002/14651858.CD003343.pub4. Review.

7.

A neglected research approach to prevent acquired drug resistance when treating new tuberculosis patients.

Moulding T.

Int J Tuberc Lung Dis. 2011 Jul;15(7):855-61. doi: 10.5588/ijtld.10.0486.

PMID:
21682959
8.

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis.

Weiner M, Benator D, Burman W, Peloquin CA, Khan A, Vernon A, Jones B, Silva-Trigo C, Zhao Z, Hodge T; Tuberculosis Trials Consortium..

Clin Infect Dis. 2005 May 15;40(10):1481-91.

PMID:
15844071
9.

Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand.

Okanurak K, Kitayaporn D, Wanarangsikul W, Koompong C.

Int J Tuberc Lung Dis. 2007 Jul;11(7):762-8.

PMID:
17609051
10.

First do no harm--adverse events, drug intolerance, and hepatotoxicity: how can we not justify directly observed therapy for treating tuberculosis?

Seaworth BJ, Armitige LY, Griffith DE.

Clin Infect Dis. 2013 Oct;57(7):1063-4. doi: 10.1093/cid/cit432. No abstract available.

PMID:
23811418
11.

Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy.

Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL.

Am J Respir Crit Care Med. 2004 Sep 1;170(5):561-6.

PMID:
15184210
12.

Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

Porco TC, Oh P, Flood JM.

Clin Infect Dis. 2013 Mar;56(6):761-9. doi: 10.1093/cid/cis989.

13.

An analysis with serious flaws.

Nunn AJ, Phillips PP.

Clin Infect Dis. 2013 Oct;57(7):1064-5. doi: 10.1093/cid/cit433. No abstract available.

PMID:
23811419
14.

Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.

Anuwatnonthakate A, Limsomboon P, Nateniyom S, Wattanaamornkiat W, Komsakorn S, Moolphate S, Chiengsorn N, Kaewsa-Ard S, Sombat P, Siangphoe U, Mock PA, Varma JK.

PLoS One. 2008 Aug 28;3(8):e3089. doi: 10.1371/journal.pone.0003089.

15.

Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips.

Pasipanodya JG, Gumbo T.

Clin Infect Dis. 2013 Oct;57(7):1065-6. doi: 10.1093/cid/cit434. No abstract available.

16.

Cost comparison of wirelessly vs. directly observed therapy for adherence confirmation in anti-tuberculosis treatment.

Au-Yeung KY, DiCarlo L.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1498-504. doi: 10.5588/ijtld.11.0868.

PMID:
23006834
17.

Effectiveness of directly observed treatment of tuberculosis: a systematic review of controlled studies.

Tian JH, Lu ZX, Bachmann MO, Song FJ.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1092-8. doi: 10.5588/ijtld.13.0867. Review.

PMID:
25189558
18.

An integrated review of directly observed therapy for tuberculosis in Latin America.

Zuñiga JA.

Hisp Health Care Int. 2015;13(1):46-54. doi: 10.1891/1540-4153.13.1.46. Review.

PMID:
25741933
19.

Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.

Reis-Santos B, Pellacani-Posses I, Macedo LR, Golub JE, Riley LW, Maciel EL.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1188-93. doi: 10.5588/ijtld.14.0776.

PMID:
26459531
20.

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis.

Rockwood N, Abdullahi LH, Wilkinson RJ, Meintjes G.

PLoS One. 2015 Sep 25;10(9):e0139017. doi: 10.1371/journal.pone.0139017. Review. Erratum in: PLoS One. 2015;10(11):e0142276.

Supplemental Content

Support Center